maladies – Prise en charge de la drépanocytose en France

This written question concerns the management and care of sickle cell disease in France. It seeks information on the current healthcare provisions and potential improvements for patients suffering from this genetic blood disorder. The question is directed towards the French government, highlighting the need for adequate support and treatment strategies for individuals affected by sickle cell disease within the country.